Loading...

Teladoc Health Inc
NYSE:TDOC

Watchlist Manager
Teladoc Health Inc Logo
Teladoc Health Inc
NYSE:TDOC
Watchlist
Price: 26.66 USD -1.73%
Updated: Nov 30, 2022

Intrinsic Value

TDOC's intrinsic value estimate is unreliable because it is based only on its relative value.

The intrinsic value of one TDOC stock under the Base Case scenario is 51.55 USD. Compared to the current market price of 26.66 USD, Teladoc Health Inc is Undervalued by 48%.

The Intrinsic Value is calculated as the average of the two valuation methods:

TDOC Intrinsic Value
Base Case
51.55 USD
Undervaluation 48%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

TDOC Profitability Score
Profitability Due Diligence

Teladoc Health Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Negative 3-Year Average ROE
Negative 3-Year Average ROIC
Negative Operating Income
Negative Net Income
39/100
Profitability
Score

Teladoc Health Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

TDOC Solvency Score
Solvency Due Diligence

Teladoc Health Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Low Interest Coverage
Low Altman Z-Score
Positive Net Debt
Short-Term Liabilities
46/100
Solvency
Score

Teladoc Health Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
69%
Gross Margin
-10%
Operating Margin
-424%
Net Margin
3%
FCF Margin
-89%
ROE
-2%
ROIC
Other

TDOC Capital Structure
Teladoc Health Inc

Market Capitalization 4.3B USD
Total Debt 1.5B USD
Minority Interest 0 USD
Preferred Equity 0 USD
Cash and Equivalents 900M USD
Short-Term Investments 0 USD
Enterprise Value 5B USD

Wall St
Price Targets

TDOC Price Targets Summary
Teladoc Health Inc

Wall Street analysts forecast TDOC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TDOC is 34.39 USD with a low forecast of 24.24 USD and a high forecast of 47.25 USD.

Lowest
Price Target
24.24 USD
9% Downside
Average
Price Target
34.39 USD
29% Upside
Highest
Price Target
47.25 USD
77% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

TDOC Competitors
Teladoc Health Inc

TDOC Suppliers & Customers
Teladoc Health Inc

Teladoc Health Inc has 8 key suppliers from 1 countries and 4 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Health Care industry.

Teladoc Health Inc has 5 key customers from 1 countries and 5 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Food Products industry.

Ownership

TDOC Shareholders
Major Shareholders

Insiders own a significant part of the company.

Top 25 shareholders own 45.6% of the company. Insiders own 2.38%. The biggest insider is Gorevic Jason N (Chief Executive Officer), who owns 0.5775% of Teladoc Health Inc.

Insiders
2.38%
Institutions
59.16%
Other
38.46%
Insiders
2.38%
Gorevic Jason N
Chief Executive Officer
Ownership
0.5775%
Market Value
24.8M USD
Shares
931 876
Tullman Glen
Director
Ownership
0.1717%
Market Value
7.4M USD
Shares
277 101
Wang Yulun
Head of Research & Development
Ownership
0.1688%
Market Value
7.3M USD
Shares
272 372
Hirschhorn Mark
Executive VP, COO and CFO
Ownership
0.1605%
Market Value
6.9M USD
Shares
258 946
Kornwasser Laizer
PRESIDENT, ENTERPRISE GROWTH
Ownership
0.1502%
Market Value
6.5M USD
Shares
242 382
Murthy Mala
CHIEF FINANCIAL OFFICER
Ownership
0.1067%
Market Value
4.6M USD
Shares
172 128
Jensen Claus Torp
CHIEF INNOVATION OFFICER
Ownership
0.0903%
Market Value
3.9M USD
Shares
145 654
Waters Michael Willem
CHIEF OPERATING OFFICER
Ownership
0.0842%
Market Value
3.6M USD
Shares
135 833
Turitz Andrew
SVP - BUSINESS DEVELOPMENT
Ownership
0.0817%
Market Value
3.5M USD
Shares
131 861
Geshuri Arnnon
CHIEF PEOPLE OFFICER
Ownership
0.0788%
Market Value
3.4M USD
Shares
127 153
Raman-Tangella Vidya
CHIEF MEDICAL OFFICER
Ownership
0.0762%
Market Value
3.3M USD
Shares
122 927
Taneja Hemant
Director
Ownership
0.0738%
Market Value
3.2M USD
Shares
119 060
Vandervoort Adam C
CHIEF LEGAL OFFICER, SECRETARY
Ownership
0.0656%
Market Value
2.8M USD
Shares
105 811
Mcclennen Peter A
President
Ownership
0.0592%
Market Value
2.5M USD
Shares
95 492
Verstraete Stephany
CHIEF MARKETING OFFICER
Ownership
0.0576%
Market Value
2.5M USD
Shares
92 905
Sides David William
Chief Operating Officer
Ownership
0.0475%
Market Value
2M USD
Shares
76 590
Trencher Daniel
SVP CORPORATE STRATEGY
Ownership
0.0463%
Market Value
2M USD
Shares
74 697
Frist William H.
Director
Ownership
0.0385%
Market Value
1.7M USD
Shares
62 076
Snow David B Jr
Director
Ownership
0.0377%
Market Value
1.6M USD
Shares
60 827
Mawhinney Tom
Director
Ownership
0.0324%
Market Value
1.4M USD
Shares
52 327
Daniel Karen L
Director
Ownership
0.0275%
Market Value
1.2M USD
Shares
44 342
Levy Lewis
Chief Medical Officer
Ownership
0.0272%
Market Value
1.2M USD
Shares
43 974
Bucaria Michelle
Chief Human Resources Officer
Ownership
0.0227%
Market Value
978k USD
Shares
36 674
Napolitano Richard J
CHIEF ACCOUNTING OFFICER
Ownership
0.0177%
Market Value
764k USD
Shares
28 644
Paulus Kenneth H
Director
Ownership
0.0107%
Market Value
461k USD
Shares
17 291
Mckinley Thomas
Director
Ownership
0.0088%
Market Value
380k USD
Shares
14 243
Fenwick Sandra L
Director
Ownership
0.0075%
Market Value
322k USD
Shares
12 070
Shedlarz David L
Director
Ownership
0.0073%
Market Value
312k USD
Shares
11 705
Smith Mark Douglas
Director
Ownership
0.0069%
Market Value
295k USD
Shares
11 081
Jacobson Catherine
Director
Ownership
0.0061%
Market Value
262k USD
Shares
9 832
Darling Helen
Director
Ownership
0.006%
Market Value
257k USD
Shares
9 656
Mcandrews Brian P
Director
Ownership
0.0056%
Market Value
242k USD
Shares
9 059
Cappucci Gabriel R.
Senior VP, Controller and CAO
Ownership
0.0055%
Market Value
237k USD
Shares
8 899
Multani Arneek
Director
Ownership
0.005%
Market Value
214k USD
Shares
8 012
Bischoff Christopher
Director
Ownership
0.0045%
Market Value
192k USD
Shares
7 195
Caridi Christopher
Chief Accounting Officer
Ownership
0.0019%
Market Value
81.8k USD
Shares
3 070
Goldstein Michael
Director
Ownership
0.0007%
Market Value
28k USD
Shares
1 049
Institutions
59.16%
Back

TDOC Insider Trading
Buy and sell transactions by insiders

Teladoc Health Inc insiders have only sold shares in the past 12 months.

During the last 12 months Teladoc Health Inc insiders have not bought any shares, and sold 3.2M USD worth of shares. The last transaction was made on Nov 30, 2022 by Trencher Daniel (SVP CORPORATE STRATEGY), who sold 30.1k USD worth of TDOC shares.

Sold
0-3
months
106k USD
3
3-6
months
399k USD
3
6-9
months
2.1M USD
8
9-12
months
624k USD
3
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
106k USD
N/A
-106k
6 Months
505k USD
N/A
-505.5k
9 Months
2.6M USD
N/A
-2.6M
12 Months
3.2M USD
N/A
-3.2M
Purchases
5
Sales
343
Why is insider trading important?

Shareholder Return

TDOC Price
Teladoc Health Inc

1M 1M
-10%
6M 6M
-22%
1Y 1Y
-74%
3Y 3Y
-66%
5Y 5Y
-28%
Annual Price Range
26.66
52w Low
23.16
52w High
102.05
Price Metrics
Average Annual Return 61.11%
Standard Deviation of Annual Returns 61.47%
Max Drawdown -92%

Company Profile

Teladoc Health Inc

Country

United States of America

Industry

Health Care

Market Cap

4.3B USD

Dividend Yield

0%

Description

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. The company is headquartered in Purchase, New York and currently employs 5,100 full-time employees. The company went IPO on 2015-07-01. The firm operates in health services segment. The firm provides virtual access to care with a portfolio of services and solutions, which includes various medical subspecialties from non-urgent, episodic needs, such as flu and upper respiratory infections, to chronic, complicated medical conditions, such as hypertension, cancer and congestive heart failure. The company provides provide virtual healthcare services on a business-to-business (B2B) basis to its clients including employers, health plans, hospitals and health systems, and insurance and financial services companies spanning the global healthcare landscape and provide services to consumers directly and through channel partners. The Company’s consumer brands, including Teladoc, Livongo, Advance Medical, Best Doctors, BetterHelp and HealthiestYou, provides access to advice and resolution for an array of healthcare needs.

Contact

NEW YORK
Purchase
2 Manhattanville Rd Ste 203
+12036352002.0
https://www.teladochealth.com/

IPO

2015-07-01

Employees

5 100

Officers

CEO & Director
Mr. Jason Nathanial Gorevic
Chief Financial Officer
Ms. Mala Murthy
Chief Legal Officer & Sec.
Mr. Adam Christian Vandervoort
Sr. VP of Corp. Devel.
Mr. Andrew Turitz
Chief Innovation Officer
Mr. Claus Torp Jensen Ph.D.
Co-Founder
Dr. George Byron Brooks
Show More
Chief Operating Officer
Mr. Mike Waters
Sr. VP, Chief Accounting Officer & Controller
Mr. Richard J. Napolitano
VP of Investor Relations
Mr. Patrick Thomas Feeley C.F.A., CPA
Director of Communication
Ms. Courtney Kraemer McLeod
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one TDOC stock?

The intrinsic value of one TDOC stock under the Base Case scenario is 51.55 USD.

Is TDOC stock undervalued or overvalued?

Compared to the current market price of 26.66 USD, Teladoc Health Inc is Undervalued by 48%.